Skip to main content

Corporate insider profile

Frances Arnold Insider Trades

Frances Arnold has reported no open-market purchases on SEC Form 4 and is a net seller of $423,358 across 2 companies. The most recent open-market transaction was reported on Oct 29, 2026. Source: SEC Form 4 filings.

Latest reported as Director of Generate Biomedicines, Inc. (GENB).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
0
Reported companies
2
Net open-market value
-$423,358.30
Latest transaction
Oct 29, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 29, 2026Generate Biomedicines, Inc. (GENB)DirectorSale11,409$16.19$184,733
Oct 29, 2026Alphabet Inc. (GOOGL)DirectorSale82$284.00$23,288
Sep 30, 2026Alphabet Inc. (GOOGL)DirectorSale83$340.45$28,257
Sep 1, 2026Generate Biomedicines, Inc. (GENB)DirectorSale1,000$16.00$16,002
Aug 28, 2026Alphabet Inc. (GOOGL)DirectorSale82$337.71$27,692
Jul 30, 2026Alphabet Inc. (GOOGL)DirectorSale82$333.39$27,338
Jun 30, 2026Alphabet Inc. (GOOGL)DirectorSale112$351.28$39,343
May 29, 2026Alphabet Inc. (GOOGL)DirectorSale102$381.00$38,862
Apr 30, 2026Alphabet Inc. (GOOGL)DirectorSale102$371.00$37,842

Common questions

Frances Arnold insider trading FAQ

Is Frances Arnold buying or selling stock?
Across all SEC Form 4 open-market filings on record, Frances Arnold is a net seller of $423,358, with no open-market purchases reported. The latest transaction was reported on Oct 29, 2026.
Which companies does Frances Arnold report insider trades for?
Frances Arnold has reported open-market trades in Generate Biomedicines, Inc. (GENB), Alphabet Inc. (GOOGL). The latest SEC-reported relationship is Director of Generate Biomedicines, Inc. (GENB).
Where does Frances Arnold's insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1665419, and refreshes this page daily.